The Renovus team reached new heights (despite the rain!) with an unforgettable treetop adventure at its recent offsite at Skytop Lodge! #privateequity #teambuilding #offsite
Renovus Capital Partners
Venture Capital and Private Equity Principals
Wayne, Pennsylvania 4,251 followers
Investing in Knowledge and Talent
About us
Renovus is a private equity firm focused on education, training, and human capital businesses. Renovus targets investments in companies with $3 to $15 million EBITDA, and will do smaller add-on acquisitions for portfolio companies.
- Website
-
http://www.renovuscapital.com
External link for Renovus Capital Partners
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 11-50 employees
- Headquarters
- Wayne, Pennsylvania
- Type
- Partnership
Locations
-
Primary
460 E Swedesford Rd
Suite 2050
Wayne, Pennsylvania 19087, US
Employees at Renovus Capital Partners
Updates
-
Our Renovus team unplugged for a few days to hear from our Founding Partners, connect as a team, and enjoy some time in nature. A few highlights included our Partners sharing their vision for the future of Renovus, enjoying delicious food, making memories among the treetops, and some very competitive rounds of Quizzo! #privateequity #teambuiliding #offsite
-
-
Renovus Capital Partners' portfolio company ToxStrategies LLC is pleased to announce the acquisition of Suttons Creek! This partnership between leading pharmaceutical solution providers enhances offerings across pharmaceutical development and commercialization. “ToxStrategies has generated significant momentum over the last year in terms of adding new service offerings to its life sciences practice,” said Jesse Serventi, Founding Partner at Renovus Capital Partners. “We are thrilled to welcome Suttons Creek into the fold, bringing deep regulatory expertise to the medical device, pharmaceutical, and combination products industries. We are confident that this acquisition will allow ToxStrategies to deliver even more value to its clients and provide numerous growth opportunities for the company." Congratulations to Laurie Couture Haws and the entire ToxStrategies team! #privateequity #growthacquisition
-
Renovus Capital Partners is pleased to announce it has published its Mid-Year Review! Read about all of our accomplishments in the first half of 2024 and where we are headed for the remainder of the year at the link below! #privateequity #midyearreview
2024 Mid-Year Review - Renovus Capital
renovuscapital.com
-
Renovus Capital Partners' portfolio company SolomonEdwards today announced it has appointed John Gulnac as its new CEO. "Renovus is excited to welcome John Gulnac as SolomonEdwards' CEO," said Managing Director Lee Minkoff. "With his deep experience in professional services and private equity-backed businesses, John is uniquely positioned to lead SolomonEdwards through its next phase of growth.” Welcome John! #privateequity #ceo
John Gulnac named Chief Executive Officer - SolomonEdwards
https://solomonedwards.com
-
Renovus Capital Partners portfolio company Behavioral Framework today announced it has acquired Behavior Consultation & Psychological Services, PLLC (“BCPS”), a premier provider of clinic, home, and school-based ABA therapy and autism diagnostic services for children in North Carolina. This partnership is a testament to the shared mission of expanding access to high-quality ABA therapy while serving clients and families across a variety of care settings. Congratulations to Kyle W., Angela West and the entire Behavioral Framework team! #privateequity #growthacquisition
Behavioral Framework Acquires Behavior Consultation & Psychological Services (BCPS) - Renovus Capital
renovuscapital.com
-
Welcome to our 2024 Summer Interns! We are thrilled to have such a great group of intelligent and extremely hard working students who are excited to learn about private equity and Renovus Capital Partners with us this summer. We look forward to their questions and contributions over the next few months! #privateequity #summerinterns
-
-
Renovus Capital Partners is excited to announce that its portfolio company, ToxStrategies LLC, has acquired Clintrex Research Corporation. “ToxStrategies has benefitted from being one of several Renovus portfolio companies in the life sciences industry, giving it access to a vast network of relationships, capabilities, and industry expertise,” said Jesse Serventi, Founding Partner at Renovus. “We are now excited to support ToxStrategies’ acquisition of Clintrex, which brings together two world class service providers to support the full pharmaceutical development pipeline, particularly in the neurodegenerative and neurological diseases space. We are confident that this acquisition will create numerous growth opportunities for the combined company." Congratulations to Laurie Couture Haws and the ToxStrategies team! #privateequity #growthacquisition
ToxStrategies Acquires Clintrex Research Corporation - Renovus Capital
renovuscapital.com
-
Our new Principal Gary Tang recently spoke with John Ross Fischer at PE Hub about his background investing in healthcare services and how he got started in private equity. Read the full article at the link below! #privateequity #healthcareservices
Renovus Capital's new principal Gary Tang eyes opportunities in healthcare services | PE Hub
pehub.com
-
Renovus Capital Partners' portfolio company, ClinicalMind, is excited to announce the acquisition of Sensified! This strategic move combines ClinicalMind's broad expertise in medical communications and training with Sensified’s strategy, content, and engagement capabilities across commercial, medical and patient advocacy clients. Congratulations to Jeanne Martel and the ClinicalMind team! #privateequity #growthacquisition
🚀 Exciting news! We are thrilled to welcome Sensified to the ClinicalMind family. Sensified is recognized for being forward-thinking, action-oriented and committed to all stakeholders, with a focus on setting a new standard in healthcare communications. This strategic move combines CM's broad expertise in medical communications and training with Sensified’s strategy, content, and engagement capabilities across commercial, medical, and patient advocacy clients. Read the full press release here: https://lnkd.in/eFiQxk6d #Healthcare #MedicalCommunications #LifeSciences #Innovation #HealthcareMarketing #PatientAdvocacy
-